10 Apr 2026Open access
Long-term immune profiling of COVID-19 recovered patients: effects of disease severity and vaccinationPublisher siteFrontiers in Immunology, SARS-CoV-2 and COVID-19 Research
UniversitiesCecilia Ngatunga
Active, last published 2026
In cardiac tumors and thrombi
Cecilia
Ngatunga
Scholar“Research focused on Cardiac tumors and thrombi and adjacent fields.”
University of Dar es Salaam
Claim Your Profile2
H-index
6
Citations
Cecilia has not officially claimed their profile. If you are Cecilia, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ecilia Ngatunga is a researcher working on Cardiac tumors and thrombi. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Cecilia's work has been cited 6 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cardiac tumors and thrombi×2Vascular Tumors and Angiosarcomas×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Dar es SalaamDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Jun 20243cites
Pneumoconiosis among artisanal miners in Chunya district, Mbeya, TanzaniaPublisher siteBMJ Case Reports, Occupational and environmental lung diseases
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Cecilia?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you